share_log

Context Therapeutics Q2 2024 Adj EPS $(0.04) Beats $(0.07) Estimate

Benzinga ·  Aug 7 17:26

Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.07) by 42.86 percent.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment